Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Meningococcal Vaccine Market, by Brand
1.4.2 Europe Meningococcal Vaccine Market, by Type
1.4.3 Europe Meningococcal Vaccine Market, by Age Group
1.4.4 Europe Meningococcal Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. Europe Meningococcal Vaccine Market by Brand
4.1 Europe Bexsero Market by Country
4.2 Europe Trumenba Market by Country
4.3 Europe Nimenrix Market by Country
4.4 Europe Menactra Market by Country
4.5 Europe Menveo Market by Country
4.6 Europe Other Brands Market by Country
Chapter 5. Europe Meningococcal Vaccine Market by Type
5.1 Europe Bivalent Market by Country
5.2 Europe Quadrivalent Market by Country
5.3 Europe Other Types Market by Country
Chapter 6. Europe Meningococcal Vaccine Market by Age Group
6.1 Europe Children (2 years & above) and Adults Market by Country
6.2 Europe Infants(0 to 2 years) Market by Country
Chapter 7. Europe Meningococcal Vaccine Market by Country
7.1 Germany Meningococcal Vaccine Market
7.1.1 Germany Meningococcal Vaccine Market by Brand
7.1.2 Germany Meningococcal Vaccine Market by Type
7.1.3 Germany Meningococcal Vaccine Market by Age Group
7.2 UK Meningococcal Vaccine Market
7.2.1 UK Meningococcal Vaccine Market by Brand
7.2.2 UK Meningococcal Vaccine Market by Type
7.2.3 UK Meningococcal Vaccine Market by Age Group
7.3 France Meningococcal Vaccine Market
7.3.1 France Meningococcal Vaccine Market by Brand
7.3.2 France Meningococcal Vaccine Market by Type
7.3.3 France Meningococcal Vaccine Market by Age Group
7.4 Russia Meningococcal Vaccine Market
7.4.1 Russia Meningococcal Vaccine Market by Brand
7.4.2 Russia Meningococcal Vaccine Market by Type
7.4.3 Russia Meningococcal Vaccine Market by Age Group
7.5 Spain Meningococcal Vaccine Market
7.5.1 Spain Meningococcal Vaccine Market by Brand
7.5.2 Spain Meningococcal Vaccine Market by Type
7.5.3 Spain Meningococcal Vaccine Market by Age Group
7.6 Italy Meningococcal Vaccine Market
7.6.1 Italy Meningococcal Vaccine Market by Brand
7.6.2 Italy Meningococcal Vaccine Market by Type
7.6.3 Italy Meningococcal Vaccine Market by Age Group
7.7 Rest of Europe Meningococcal Vaccine Market
7.7.1 Rest of Europe Meningococcal Vaccine Market by Brand
7.7.2 Rest of Europe Meningococcal Vaccine Market by Type
7.7.3 Rest of Europe Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Unique Offerings 
